NASDAQ : ABCM

Abcam plc

$23.99 USD

$0.01 (0.04%)

Volume
7.43M
Average Volume
5.13M
Market Capitalization
$5.52B
P/E Ratio
-478.52
Dividend Yield
0.00%
Price Target
Year High
$25.32
Year Low
$12.48
Day High
Day Low
Payout Ratio
-$2.94
Current Ratio
$1.27

Industry, Sector & symbol

Stock Exchange NASDAQ
CEO Alan Thomas Hirzel BS,
Industry Biotechnology
Sector Healthcare
Current Symbol ABCM
CUSIP 000380204
CIK 0001492074
Web https://www.abcam.com
Phone 44 12 2369 6000
Currency USD
Employees 1760
Country GB

Liquidity

Debt-to-Equity Ratio 0.31
Payout Ratio -2.94
Current Ratio 1.27
Quick Ratio 0.93
Cash Ratio 0.44

Sales & Book Value

Annual Sales $361.7M
Price / Sales 11.33
Cash Flow -0.06
Price / Cash Flow -325.15
Price / Book 5.60

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecast Upside/Downside %
Consensus Rating N/A
Rating Score(0-5) 0
Research Coverage 5 Analysts

Profitability

EPS (Most Recent Fiscal Year) -$0.0372
Trailing P/E Ratio -478.52
PEG Ratio -4.79
P/E Growth -4.79
Net Income -$8.5M
Net Margin -2.35%
Pretax Margin -4.31%
Return on Equity -1.23%
Return on Assets -0.80%

Financials Score

AltmanZ Score 9.41
Piotroski Score 6.00
Working Capital 66.9M
Total Assets 1.03B
Ebit 43.61M
Market Cap 4.12B
Total Liabilities 307.9M

Poll Results

About Abcam plc (NASDAQ:ABCM) Stock

Abcam plc operates as a prominent life science enterprise, dedicated to the innovation, creation, and supply of crucial reagents and instruments. These fundamental resources are instrumental in supporting diverse scientific investigations, diagnostic applications, and the advancement of pharmaceutical drug discovery initiatives. Its comprehensive product portfolio features primary and secondary antibodies, conjugated antibodies paired with their respective kits, both singleplex and multiplex immunoassays, as well as a variety of proteins and peptides, including cytokines. Furthermore, the company provides edited cell lines, lysates, cellular activity kits, miRNA kits, biochemical compounds, and specialized tools for analyzing cell signaling pathways. Abcam serves a broad customer base, enc ... ompassing researchers and scientists within academic and institutional environments, alongside professionals at pharmaceutical, biotechnology, and diagnostic companies. The company boasts a global presence, conducting operations across the Americas, Europe, the Middle East, Africa, China, Japan, and the wider Asia Pacific region. Product distribution is primarily facilitated via its online platform. Founded in 1998, Abcam plc is headquartered in Cambridge, United Kingdom.

Frequently Asked Questions

What is the current Abcam plc (ABCM) stock price?

Abcam plc(NASDAQ:ABCM) stock price is $23.99 in the last trading session. During the trading session, ABCM stock reached the peak price of $25.32 while $12.48 was the lowest point it dropped to. The percentage change in ABCM stock occurred in the recent session was 0.04% while the dollar amount for the price change in ABCM stock was $0.01.

ABCM's industry and sector of operation?

The NASDAQ listed ABCM is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of ABCM?

Marc Leigh Russell Perkins | General Counsel & Company Secretary
Alan Thomas Hirzel | Chief Executive Officer & Executive Director
Nick Skinner | Senior Vice President of Human Resources
Alejandra Solache | Senior Vice President of Research & Development
|

How many employees does ABCM have?

Number of ABCM employees currently stands at 1760. ABCM operates from Discovery Drive, Cambridge, None CB2 0AX, GB.

Link for ABCM official website?

Official Website of ABCM is: https://www.abcam.com

How do I contact ABCM?

ABCM could be contacted at phone #44 12 2369 6000 and can also be accessed through its website. ABCM operates from Discovery Drive, Cambridge, None CB2 0AX, GB.

How many shares of ABCM are traded daily?

The average number of ABCM shares traded daily for last 3 months was 5.13M.

What is the market cap of ABCM currently?

The market value of ABCM currently stands at $5.52B with its latest stock price at $23.99